State MA
Clinical Trials in Massachusetts
Recruiting clinical trials with at least one study location in Massachusetts. Data updated daily from ClinicalTrials.gov.
Top Conditions in Massachusetts
Frequently Asked Questions — Clinical Trials in Massachusetts
How many clinical trials are currently recruiting in Massachusetts?
ClinicalMetric currently tracks 482 actively recruiting clinical trials with at least one location in Massachusetts. The total number of registered studies—including active but not currently enrolling trials—is 482. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Massachusetts?
Massachusetts hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Multiple Myeloma, Obesity, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Massachusetts serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Massachusetts?
To join a clinical trial in Massachusetts, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Massachusetts maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Massachusetts
NCT06710483 N/A
Recruiting
A Pilot Project to Facilitate Dental Care and Reduce Barriers For Youth With Dis...
Condition
Intellectual Disability, Variable
Enrollment
50 pts
Location
United States
Sponsor
Boston University
NCT06623422 Phase 3
Recruiting
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
680 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT07140783 Phase 3
Recruiting
OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Kerato...
Condition
Vision Loss Night
Enrollment
200 pts
Location
United States
Sponsor
Ocuphire Pharma, Inc.
NCT05410977 N/A
Recruiting
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neopl...
Condition
Colorectal Carcinoma
Enrollment
750 pts
Location
United States
Sponsor
Mayo Clinic
NCT05555875 N/A
Recruiting
Toward Understanding Drivers of Patient Engagement With Digital Mental Health In...
Condition
Depression
Enrollment
76 pts
Location
United States
Sponsor
Brigham and Women's Hospital
NCT07420283 Phase 2
Recruiting
A Study of Brenipatide in Participants With Opioid Use Disorder
Condition
Opioid Use Disorder
Enrollment
465 pts
Location
United States, Canada, Puerto Rico
Sponsor
Eli Lilly and Company
NCT06858579 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic In...
Condition
Chronic Inflammatory Demyelinating Polyneuropathy
Enrollment
256 pts
Location
United States, Argentina, Australia
Sponsor
Dianthus Therapeutics
NCT06532279 Phase 2
Recruiting
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the ...
Condition
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Enrollment
98 pts
Location
United States
Sponsor
NRG Oncology
NCT03821129 N/A
Recruiting
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reducti...
Condition
Stroke
Enrollment
636 pts
Location
United States
Sponsor
W.L.Gore & Associates
NCT06472245 Phase 3
Recruiting
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung...
Condition
Patients With Non-Small Cell Lung Cancer
Enrollment
363 pts
Location
United States, Belgium, Canada
Sponsor
OSE Immunotherapeutics
NCT06999954 N/A
Recruiting
Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform
Condition
Shwachman-Diamond Syndrome
Enrollment
8,000 pts
Location
United States
Sponsor
Shwachman-Diamond Syndrome All
NCT04701645 Phase 1
Recruiting
Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer
Condition
Ovarian Cancer
Enrollment
20 pts
Location
United States
Sponsor
Brigham and Women's Hospital
NCT05265429 N/A
Recruiting
Biology of Young Lung Cancer Study: The YOUNG LUNG Study
Condition
Non Small Cell Lung Cancer
Enrollment
500 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute
NCT06162221 Phase 1, Phase 2
Recruiting
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Condition
Non-Small Cell Lung Cancer, NSCLC
Enrollment
616 pts
Location
United States, Australia, Denmark
Sponsor
Revolution Medicines, Inc.
NCT04899947 N/A
Recruiting
Child and Adolescent Registry for Participants With Narcolepsy
Condition
Narcolepsy
Enrollment
500 pts
Location
United States
Sponsor
Jazz Pharmaceuticals
NCT06099743 N/A
Recruiting
ASCENT Intervention for Brain Tumor Patients
Condition
Malignant Brain Tumor
Enrollment
100 pts
Location
United States
Sponsor
Massachusetts General Hospital
NCT06130735 N/A
Recruiting
Impact of Intensive Computerized Cognitive Training
Condition
Acquired Brain Injury
Enrollment
30 pts
Location
United States
Sponsor
Brigham and Women's Hospital
NCT05490225 N/A
Recruiting
Access Cannulation Trial II
Condition
Dialysis; Complications
Enrollment
100 pts
Location
United States
Sponsor
Voyager Biomedical
NCT02915198 Phase 4
Recruiting
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuT...
Condition
Prediabetic State
Enrollment
7,410 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT05201781 Phase 4
Recruiting
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autole...
Condition
Multiple Myeloma
Enrollment
295 pts
Location
United States, Belgium, China
Sponsor
Janssen Research & Development
NCT07500506 Phase 3
Recruiting
A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth D...
Condition
Lyme Disease
Enrollment
1,712 pts
Location
United States, Canada
Sponsor
Pfizer
NCT06488378 Phase 1
Recruiting
Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- ...
Condition
Breast Cancer
Enrollment
20 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute
NCT07434843 Phase 2
Recruiting
PH 2 Pemigatinib in SDH-deficient GIST
Condition
SDH Gene Mutation
Enrollment
24 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute
NCT06433752 N/A
Recruiting
A Study Evaluating the Real World Experience of Participants Treated With BRIUMV...
Condition
Relapsing Multiple Sclerosis
Enrollment
500 pts
Location
United States, Puerto Rico
Sponsor
TG Therapeutics, Inc.
NCT06252493 N/A
Recruiting
Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collag...
Condition
Crohn Disease
Enrollment
25 pts
Location
United States
Sponsor
Massachusetts General Hospital
Page 1 of 20 — 482 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology